KM Research Hub
← 返回论文库
待处理 入排:排除 图源:待检查

Erratum: Elacestrant (oral selective estrogen receptor degrader) Versus Standard Endocrine Therapy for Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: Results From the Randomized Phase III EMERALD Trial.

J Clin Oncol 41(23) 3962

PMID37364222
PMCID-
DOI10.1200/JCO.23.01239
发表日期2023-06-26
摘要

摘要

无摘要

KM 提取结果

0 个 Figure · 0 个 KM 面板

尚未提取到 KM 面板。